Skip to main content

NALBUPHINE HCI

NDC 51662-1420 · HF Acquisition Co LLC, DBA HealthFirst

Generic nameNALBUPHINE HCI
Dosage formINJECTION, SOLUTION
RouteINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Active ingredient(s)NALBUPHINE HYDROCHLORIDE
Strength10 mg/mL
Pharmacologic classCompetitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]
Marketing categoryANDA

Packages

51662-1420-1 — 1 VIAL, MULTI-DOSE in 1 CARTON (51662-1420-1) / 10 mL in 1 VIAL, MULTI-DOSE

Billed under HCPCS

J2300 — Injection, nalbuphine hydrochloride, per 10 mg Medicare Part B payment limit (ASP + 6%): $4.29

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0404-9766 — nalbuphine hydrochloride, 0404-9767 — nalbuphine hydrochloride, 0404-9918 — Nalbuphine Hydrochloride, 0409-1463 — NALBUPHINE HYDROCHLORIDE, 0409-1464 — NALBUPHINE HYDROCHLORIDE, 0409-1465 — NALBUPHINE HYDROCHLORIDE, 0409-1467 — NALBUPHINE HYDROCHLORIDE, 51662-1418 — NALBUPHINE HCI, 70069-661 — Nalbuphine hydrochloride, 70069-662 — Nalbuphine hydrochloride, 70069-671 — Nalbuphine hydrochloride, 70069-672 — Nalbuphine hydrochloride, 71872-7114 — NALBUPHINE HYDROCHLORIDE, 71872-7320 — NALBUPHINE HYDROCHLORIDE, 71872-7331 — Nalbuphine hydrochloride, 84549-464 — NALBUPHINE HYDROCHLORIDE

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels